Additional studies in cardiomyocytes may be required to uncover a clearer pathogenetic link between the Ser358Leu mutation in TMEM43 and the development of ARVC. This evidence concerns the gene TMEM43 and arrhythmogenic right ventricular cardiomyopathy.